GlassScriptPhysician profile
David W Mcdermott
NPI 1730184177
$2,617.33
in general payments reported to CMS, 2019-2025
29 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $153 · 2021: $223 · 2022: $223 · 2023: $837 · 2024: $661 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $390.42 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $332.64 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $208.63 | 2023-2025 | Gemtesa, Orgovyx |
| Olympus America INC. | $163.79 | 2023-2025 | Itind System, Tecoflex |
| Dendreon Pharmaceuticals LLC | $162.72 | 2021-2024 | Provenge |
| Pfizer INC. | $139.49 | 2019-2025 | |
| Telix Pharmaceuticals | $135.50 | 2023-2024 | Illuccix |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Endo Pharmaceuticals INC. | $118.05 | 2021-2023 | Xiaflex, Aveed |
| Abbvie INC. | $99.58 | 2019-2024 | |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
| Neotract INC. | $94.15 | 2020 | |
| Myovant Sciences INC. | $84.01 | 2021-2022 | |
| Urogen Pharma, INC. | $71.01 | 2025 | |
| Astellas Pharma US INC | $67.65 | 2023 | Myrbetriq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.22 | 2020-2024 | Keytruda |
| Ferring Pharmaceuticals INC. | $34.34 | 2024-2025 | Adstiladrin |
| Renovia INC | $31.20 | 2020 | |
| Tolmar, INC. | $27.73 | 2023 | |
| Valencia Technologies Corporation | $25.74 | 2023 | Ecoin Device Kit |
| Steris Corporation | $25.21 | 2024 | |
| Laborie Medical Technologies Corp. | $23.52 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $23.48 | 2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $19.72 | 2024 | |
| Boston Scientific Corporation | $18.65 | 2019 | |
| Abc Home Medical Supply, INC. | $18.02 | 2024 | |
| Myriad Genetic Laboratories, INC. | $14.40 | 2023 | Bracanalysis Cdx |
| Intuitive Surgical, INC. | $12.93 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.